The present system of radiation protection assumes that exposure at low doses and/or low
dose-rates leads to health risks linearly related to the dose. They are evaluated by a …

Small noncoding RNAs, as post-translational regulators of many target genes, are not only
markers of neoplastic disease initiation and progression, but also markers of response to …

Colorectal cancer, a leading cause of mortality worldwide, is a multistep disorder that results
from the alteration of genetic and epigenetic mechanisms under contextual influence …

Ionizing radiation exposure from medical diagnostic imaging has greatly increased over the
last few decades. Approximately 80% of patients who undergo medical imaging are …

Cutaneous melanoma is a lethal disease, even when diagnosed in advanced stages.
Although recent progress in biology and treatment has dramatically improved survival rates …

Radiotherapy (RT) is one of the mainstay treatments for prostate cancer (PCa), a highly
prevalent neoplasm among males worldwide. About 30% of newly diagnosed PCa patients …

Radiotherapy, in addition to surgery and systemic chemotherapy, remains the core of the
current clinical management of cancer. Radioresistance is one of the major causes of …

Genomic DNA in eukaryotic cells is basically divided into chromosomes, each consisting of
a single huge nucleosomal fiber. It is now clear that chromatin structure and dynamics play a …

The morbidity and mortality of lung cancer are increasing, seriously threatening human
health and life. Non-small cell lung cancer (NSCLC) has an insidious onset and is not easy …

Despite recent progress in understanding the cancer signaling pathways and in developing
new therapeutic strategies, however, the resistance of colorectal cancer (CRC) cells to …